SEEGENE USA, INC.

SEEGENE USA INC specializes in the development and supply of advanced in-vitro diagnostic substances, with a focused expertise in molecular detection kits for infectious disease screening. Their core capability centers on the design, manufacturing, and deployment of high-sensitivity nucleic acid-based assays, particularly for human papillomavirus (HPV) genotyping and multiplex pathogen detection. Leveraging proprietary molecular diagnostics technology, they deliver clinically validated, automated platforms that enable precise, high-throughput analysis in public health and clinical laboratory settings. Their differentiation lies in the integration of multiplex PCR and next-generation detection chemistry, allowing simultaneous identification of multiple HPV subtypes and other pathogens from a single sample—critical for precision screening and epidemiological surveillance. The company has delivered diagnostic solutions to the Department of Health and Human Services, primarily supporting public health initiatives involving infectious disease monitoring and prevention programs. Their work with HHS aligns with national priorities in cervical cancer prevention and sexually transmitted infection control, positioning them as a trusted provider of laboratory-ready diagnostic reagents for federal health surveillance networks. SEEGENE USA INC operates within the in-vitro diagnostic substance manufacturing sector (NAICS 325413), specializing in molecular diagnostics for infectious disease detection. Their market positioning is defined by innovation in multiplexed nucleic acid testing, serving clinical laboratories, public health agencies, and reference testing networks that require high-accuracy, scalable diagnostic tools. They are not broadly diversified across medical device or pharmaceutical manufacturing but are narrowly focused on the niche of molecular assay development for viral pathogen detection. As a Level 2 corporate entity headquartered in Irvine, California, SEEGENE USA INC is a U.S.-based subsidiary with no federal certifications on record. Their geographic presence is concentrated in Southern California, serving federal and state health partners through direct supply of diagnostic kits and associated technical support infrastructure.